IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 225 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $7,089,815 | -43.1% | 180,219 | -64.8% | 0.01% | -48.1% |
| Q1 2023 | $12,462,191 | +15.0% | 512,215 | +1.2% | 0.03% | +12.5% |
| Q4 2022 | $10,836,992 | -3.6% | 506,165 | -19.2% | 0.02% | -14.3% |
| Q3 2022 | $11,241,000 | +165.1% | 626,624 | +42.2% | 0.03% | +180.0% |
| Q2 2022 | $4,240,000 | +21.2% | 440,738 | +112.0% | 0.01% | +42.9% |
| Q1 2022 | $3,499,000 | +50.9% | 207,932 | +49.9% | 0.01% | +75.0% |
| Q4 2021 | $2,319,000 | +64.5% | 138,689 | +59.8% | 0.00% | +33.3% |
| Q3 2021 | $1,410,000 | – | 86,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |